{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:41:27Z","timestamp":1786995687026,"version":"build-2736575974"},"reference-count":170,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.phrs.2007.09.001","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T07:21:58Z","timestamp":1189581718000},"page":"406-417","source":"Crossref","is-referenced-by-count":22,"title":["Modulation of the endocannabinoid system: Therapeutic potential against cocaine dependence"],"prefix":"10.1016","volume":"56","author":[{"given":"Gianluigi","family":"Tanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2007.09.001_bib1","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1073\/pnas.92.26.12304","article-title":"Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the \u201cshell\u201d as compared with the \u201ccore\u201d of the rat nucleus accumbens","volume":"92","author":"Pontieri","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.phrs.2007.09.001_bib2","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common \u03bc1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.phrs.2007.09.001_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1460-9568.1997.tb01375.x","article-title":"Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine","volume":"9","author":"Tanda","year":"1997","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2006.03880.x","article-title":"Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats","volume":"98","author":"Solinas","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.phrs.2007.09.001_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1749-6632.1999.tb09283.x","article-title":"Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell\/extended amygdala dopamine","volume":"877","author":"Di Chiara","year":"1999","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)03344-9","article-title":"Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine","volume":"954","author":"Gonzalez","year":"2002","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(01)00186-7","article-title":"Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels","volume":"66","author":"Gonzalez","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.4152-06.2007","article-title":"Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation","volume":"27","author":"Cheer","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2007.09.001_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.phrs.2007.09.001_bib10","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1523\/JNEUROSCI.23-32-10311.2003","article-title":"Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala","volume":"23","author":"Huang","year":"2003","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.phrs.2007.09.001_bib11","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1073\/pnas.122149199","article-title":"Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens","volume":"99","author":"Robbe","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.phrs.2007.09.001_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1196\/annals.1300.013","article-title":"Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens","volume":"1003","author":"Robbe","year":"2003","journal-title":"Ann NY Acad Sci"},{"issue":"12","key":"10.1016\/j.phrs.2007.09.001_bib13","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nn757","article-title":"Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine","volume":"4","author":"Thomas","year":"2001","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.phrs.2007.09.001_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","article-title":"Incentive-sensitization and addiction","volume":"96","author":"Robinson","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.phrs.2007.09.001_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of the neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2007.09.001_bib17","first-page":"351","article-title":"The effect of in vivo treatment with (\u2212) delta 1-tetrahydrocannabinol, and other psychoactive drugs on the in vitro uptake of biogenic amines","volume":"22\u201323","author":"Hershkowitz","year":"1978","journal-title":"Adv Biosci"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib18","first-page":"74","article-title":"Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes","volume":"194","author":"Banerjee","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib19","first-page":"345","article-title":"Some structural requirements for inhibition of high-affinity synaptosomal serotonin uptake by cannabinoids","volume":"12","author":"Johnson","year":"1976","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","article-title":"\u03949-Tetrahydrocannabinol produces naloxoneblockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis","volume":"102","author":"Chen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2007.09.001_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-3940(91)90739-G","article-title":"Strain-specific facilitation of dopamine efflux by \u03949-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study","volume":"129","author":"Chen","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.phrs.2007.09.001_bib22","unstructured":"Seillier AJ, Price DA, Giuffrida A. Effects of endocannabinoids on dopamine uptake in rat caudate-putamen, nucleus accumbens, and prefrontal cortex. Program No. 35.3\/C41. 2006 Neuroscience Meeting Planner. Atlanta, GA: Society for Neuroscience; 2006. Online."},{"key":"10.1016\/j.phrs.2007.09.001_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.phrs.2007.09.001_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0024-3205(90)90132-B","article-title":"Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study","volume":"46","author":"Ritz","year":"1990","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1300\/J069v12n01_03","article-title":"Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics","volume":"12","author":"Miller","year":"1993","journal-title":"J Addict Dis"},{"issue":"3\u20134","key":"10.1016\/j.phrs.2007.09.001_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1300\/J251v08n03_03","article-title":"The diagnosis of alcohol and cannabis dependence in cocaine dependence","volume":"8","author":"Miller","year":"1990","journal-title":"Adv Alcohol Subst Abuse"},{"issue":"7","key":"10.1016\/j.phrs.2007.09.001_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/10673220500243364","article-title":"Genetic determinants of addiction to opioids and cocaine","volume":"13","author":"Saxon","year":"2005","journal-title":"Harv Rev Psychiatry"},{"issue":"15","key":"10.1016\/j.phrs.2007.09.001_bib29","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1021\/jm9706729","article-title":"Pharmacotherapies for treatment of cocaine abuse: preclinical aspects","volume":"42","author":"Carroll","year":"1999","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.phrs.2007.09.001_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic\u2014a focus on analogues of benztropine and rimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med Res Rev"},{"issue":"10","key":"10.1016\/j.phrs.2007.09.001_bib31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.mp.4001560","article-title":"Human cannabinoid receptor 1: 5\u2032 exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse","volume":"9","author":"Zhang","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.phrs.2007.09.001_bib32","series-title":"Behavioral models in psychopharmacology: theoretical, industrial and clinic perspectives","first-page":"485","article-title":"Screening for abuse and dependence liabilities","author":"Sanger","year":"1991"},{"issue":"6","key":"10.1016\/j.phrs.2007.09.001_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-6147(00)01482-6","article-title":"The endocannabinoid system as a target for therapeutic drugs","volume":"21","author":"Piomelli","year":"2000","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.phrs.2007.09.001_bib34","first-page":"672","article-title":"The endocannabinoid system: a drug discovery perspective","volume":"6","author":"Piomelli","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.phrs.2007.09.001_bib36","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"issue":"6441","key":"10.1016\/j.phrs.2007.09.001_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2007.09.001_bib40","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.phrs.2007.09.001_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-3084(02)00143-3","article-title":"Cannabinergic ligands","volume":"121","author":"Palmer","year":"2002","journal-title":"Chem Phys Lipids"},{"issue":"24","key":"10.1016\/j.phrs.2007.09.001_bib42","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2007.09.001_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-3084(02)00149-4","article-title":"Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition","volume":"121","author":"Hajos","year":"2002","journal-title":"Chem Phys Lipids"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.phrs.2007.09.001_bib45","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.phrs.2007.09.001_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.phrs.2007.09.001_bib48","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.phrs.2007.09.001_bib49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"issue":"6644","key":"10.1016\/j.phrs.2007.09.001_bib50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"issue":"Pt 2","key":"10.1016\/j.phrs.2007.09.001_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/bj3220671","article-title":"Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells","volume":"322","author":"Bisogno","year":"1997","journal-title":"Biochem J"},{"issue":"36","key":"10.1016\/j.phrs.2007.09.001_bib52","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1073\/pnas.0601832103","article-title":"A biosynthetic pathway for anandamide","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6828","key":"10.1016\/j.phrs.2007.09.001_bib53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.phrs.2007.09.001_bib54","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.phrs.2007.09.001_bib55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/156800705774933104","article-title":"Endocannabinoid metabolic pathways and enzymes","volume":"4","author":"Ligresti","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2007.09.001_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-3084(00)00191-2","article-title":"The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes","volume":"108","author":"Hillard","year":"2000","journal-title":"Chem Phys Lipids"},{"issue":"5","key":"10.1016\/j.phrs.2007.09.001_bib57","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.bjp.0705468","article-title":"Cellular accumulation of anandamide: consensus and controversy","volume":"140","author":"Hillard","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2004.07.008","article-title":"Anandamide transport","volume":"104","author":"McFarland","year":"2004","journal-title":"Pharmacol Ther"},{"issue":"5329","key":"10.1016\/j.phrs.2007.09.001_bib59","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science"},{"issue":"40","key":"10.1016\/j.phrs.2007.09.001_bib60","doi-asserted-by":"crossref","first-page":"23823","DOI":"10.1074\/jbc.270.40.23823","article-title":"Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide","volume":"270","author":"Ueda","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib62","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib63","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/jpet.106.114124","article-title":"The endogenous cannabinoid anandamide produces THC-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase (FAAH) but not by inhibition of anandamide transport","volume":"321","author":"Solinas","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2007.09.001_bib64","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80577","article-title":"Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys","volume":"3","author":"Tanda","year":"2000","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib65","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(01)00130-9","article-title":"The endocannabinoid nervous system: unique opportunities for therapeutic intervention","volume":"90","author":"Porter","year":"2001","journal-title":"Pharmacol Ther"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2007.09.001_bib67","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"51","key":"10.1016\/j.phrs.2007.09.001_bib68","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-006-0506-0","article-title":"Effects of endocannabinoid neurotransmission modulators on brain stimulation reward","volume":"188","author":"Vlachou","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2007.09.001_bib70","first-page":"46","article-title":"The measurement of the influence of drugs on voluntary activity in mice","volume":"8","author":"Dews","year":"1953","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib71","first-page":"373","article-title":"Cocaine: discussion on the role of dopamine in the biochemical mechanism of action","volume":"vol. 21","author":"Scheel-Kruger","year":"1977"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib73","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0091-3057(97)00043-9","article-title":"Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat","volume":"58","author":"Swanson","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"issue":"15","key":"10.1016\/j.phrs.2007.09.001_bib74","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1523\/JNEUROSCI.23-15-06295.2003","article-title":"Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core","volume":"23","author":"Sellings","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib75","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1124\/jpet.105.100339","article-title":"Evidence for multiple sites within rat ventral striatum mediating cocaine-conditioned place preference and locomotor activation","volume":"317","author":"Sellings","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib76","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0306-4522(02)00247-6","article-title":"Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1\/D2 agonists","volume":"113","author":"Ikemoto","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-3565(24)38113-3","article-title":"Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo","volume":"289","author":"Tolliver","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib78","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/jpet.104.080465","article-title":"Effects of 4\u2032-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine","volume":"313","author":"Tanda","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib79","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/jpet.106.118067","article-title":"Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats","volume":"321","author":"Tanda","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2007.09.001_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.phrs.2007.09.001_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostatis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.phrs.2007.09.001_bib82","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib83","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0091-3057(78)90320-9","article-title":"Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats","volume":"8","author":"Pryor","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.phrs.2007.09.001_bib84","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0024-3205(99)00309-4","article-title":"Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat","volume":"65","author":"Ferrari","year":"1999","journal-title":"Life Sci"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2007.09.001_bib85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2005.05.014","article-title":"WIN 55,212-2-induced reduction of cocaine hyperlocomotion: possible inhibition of 5-HT(3) receptor function","volume":"517","author":"Przegalinski","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib86","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1016\/j.phrs.2007.09.001_bib87","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib88","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/syn.10121","article-title":"Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5HT3 receptor-mediated responses in Xenopus oocytes","volume":"46","author":"Oz","year":"2002","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib89","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s002130050987","article-title":"Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils","volume":"144","author":"Poncelet","year":"1999","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.euroneuro.2004.04.003","article-title":"Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization","volume":"15","author":"Lesscher","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib91","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002130050518","article-title":"Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats","volume":"135","author":"Chaperon","year":"1998","journal-title":"Psychopharmacology"},{"issue":"6837","key":"10.1016\/j.phrs.2007.09.001_bib92","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35079077","article-title":"Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons","volume":"411","author":"Ungless","year":"2001","journal-title":"Nature"},{"issue":"1\u20133","key":"10.1016\/j.phrs.2007.09.001_bib93","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02740682","article-title":"Behavioral sensitization and tolerance to cocaine and the occupation of dopamine receptors by dopamine","volume":"11","author":"Martin-Iverson","year":"1995","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.phrs.2007.09.001_bib94","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(01)01056-1","article-title":"Behavioral sensitization to heroin by cannabinoid pretreatment in the rat","volume":"421","author":"Pontieri","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib95","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0006-8993(01)02158-8","article-title":"Behavioral sensitization to WIN55212.2 in rats pretreated with heroin","volume":"898","author":"Pontieri","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2007.09.001_bib96","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1476-5381.1993.tb13989.x","article-title":"Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide","volume":"110","author":"Pertwee","year":"1993","journal-title":"Br J Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2007.09.001_bib97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(98)00851-6","article-title":"Chronic (\u2212)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats","volume":"365","author":"Gorriti","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib98","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0091-3057(02)00910-3","article-title":"Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats","volume":"73","author":"Muschamp","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib99","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0028-3908(01)00039-9","article-title":"Chronic treatment with delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction","volume":"41","author":"Lamarque","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2007.09.001_bib100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002130100875","article-title":"Behavioural sensitization after repeated exposure to delta(9)-tetrahydrocannabinol and cross-sensitization with morphine","volume":"158","author":"Cadoni","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib101","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(98)00433-6","article-title":"Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine","volume":"354","author":"Arnold","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib102","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1046\/j.1460-9568.2000.00287.x","article-title":"Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice","volume":"12","author":"Martin","year":"2000","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1016\/j.phrs.2007.09.001_bib103","first-page":"806","article-title":"Involvement of cannabinoid CB(1) receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine","volume":"58","author":"Filip","year":"2006","journal-title":"Pharmacol Rep"},{"issue":"10","key":"10.1016\/j.phrs.2007.09.001_bib104","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","article-title":"A cannabinoid mechanism in relapse to cocaine seeking","volume":"7","author":"De Vries","year":"2001","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.phrs.2007.09.001_bib106","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","article-title":"Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues","volume":"56","author":"Tzschentke","year":"1998","journal-title":"Prog Neurobiol"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","article-title":"Cannabinoids: reward, dependence, and underlying neurochemical mechanisms\u2014a review of recent preclinical data","volume":"169","author":"Tanda","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2007.09.001_bib108","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0024-3205(95)00191-8","article-title":"Conditioned place preference induced by \u03949-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward","volume":"56","author":"Lepore","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2007.09.001_bib109","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s002130050013","article-title":"A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice","volume":"147","author":"Valjent","year":"2000","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib110","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0306-4522(01)00210-X","article-title":"Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system","volume":"104","author":"Braida","year":"2001","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.10.043","article-title":"Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats","volume":"506","author":"Braida","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib112","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","article-title":"Motivational effects of cannabinoids are mediated by \u03bc and \u03ba-opioid receptors","volume":"22","author":"Ghozland","year":"2002","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib113","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.fbp.0000197460.16516.81","article-title":"Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of delta-9-tetrahydrocannabinol in rats","volume":"17","author":"Le Foll","year":"2006","journal-title":"Behav Pharmacol"},{"issue":"6","key":"10.1016\/j.phrs.2007.09.001_bib114","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/mol.54.6.1064","article-title":"SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity","volume":"54","author":"Pan","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0701915","article-title":"Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors","volume":"124","author":"MacLennan","year":"1998","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib116","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)01160-6","article-title":"SR141716A is an inverse agonist at the human cannabinoid CB1 receptor","volume":"334","author":"Landsman","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib117","series-title":"Modern methods in pharmacology, vol. 6. Testing and evaluation of drugs of abuse","first-page":"193","article-title":"Discriminative stimulus effects of drugs: relationship to potential for abuse","author":"Holtzman","year":"1990"},{"key":"10.1016\/j.phrs.2007.09.001_bib118","first-page":"61","article-title":"Discriminative stimulus effects of cocaine","volume":"116","author":"Woolverton","year":"1991","journal-title":"NIDA Res Monogr"},{"issue":"8","key":"10.1016\/j.phrs.2007.09.001_bib119","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0028-3908(84)90003-0","article-title":"Discriminative stimulus properties of cocaine. Effects of apomorphine, haloperidol, procaine and other drugs","volume":"23","author":"Jarbe","year":"1984","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF00427906","article-title":"Drug discrimination procedures: roles of relative stimulus control in two-drug cases","volume":"86","author":"Swedberg","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2007.09.001_bib121","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/h0058775","article-title":"Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain","volume":"47","author":"Olds","year":"1954","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.phrs.2007.09.001_bib122","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","article-title":"Addictive drugs and brain stimulation reward","volume":"19","author":"Wise","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.phrs.2007.09.001_bib123","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.ps.32.020181.002515","article-title":"The central basis of motivation: intracranial self-stimulation studies","volume":"32","author":"Olds","year":"1981","journal-title":"Ann Rev Psychol"},{"key":"10.1016\/j.phrs.2007.09.001_bib124","first-page":"PL365","article-title":"Genetic differences in \u03949-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains","volume":"58","author":"Lepore","year":"1996","journal-title":"Life Sci (Pharmacol Lett)"},{"key":"10.1016\/j.phrs.2007.09.001_bib125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0024-3205(01)01366-2","article-title":"Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats","volume":"70","author":"Arnold","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2007.09.001_bib126","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/nbdi.1998.0219","article-title":"Cannabinoid transmission and reward related events","volume":"5","author":"Gardner","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.phrs.2007.09.001_bib127","first-page":"567","article-title":"Cannabis and brain-stimulation reward","volume":"22\u201323","author":"Pradhan","year":"1978","journal-title":"Adv Biosci"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-4328(02)00370-4","article-title":"WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation","volume":"141","author":"Vlachou","year":"2003","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(93)90298-2","article-title":"Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient","volume":"621","author":"Chen","year":"1993","journal-title":"Brain Res"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2007.09.001_bib130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2003.08.045","article-title":"Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter","volume":"478","author":"Chen","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2007.09.001_bib131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0091-3057(80)90222-1","article-title":"Effects of body weight levels on cannabis self-administration","volume":"13","author":"Takahashi","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2007.09.001_bib132","first-page":"395","article-title":"Cross self-administration of delta 9-tetrahydrocannabinol and D-amphetamine in rats","volume":"14","author":"Takahashi","year":"1981","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.phrs.2007.09.001_bib133","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","article-title":"Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice","volume":"85","author":"Martellotta","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2007.09.001_bib134","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002130100734","article-title":"Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats","volume":"156","author":"Fattore","year":"2001","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pbb.2005.01.026","article-title":"Self-administration of cannabinoids by experimental animals and human marijuana smokers","volume":"81","author":"Justinova","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2007.09.001_bib136","first-page":"1","article-title":"Similarities in animal and human drug-taking behavior","volume":"vol. 1","author":"Griffiths","year":"1980"},{"key":"10.1016\/j.phrs.2007.09.001_bib137","first-page":"43","article-title":"A summary of the results of a drug selfadministration study using substitution procedures in rhesus monkeys","volume":"30","author":"Johanson","year":"1978","journal-title":"Bull Narcotics"},{"issue":"5","key":"10.1016\/j.phrs.2007.09.001_bib138","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0149-7634(99)00015-9","article-title":"Preclinical research on cocaine self-administration: environmental determinants and their interaction with pharmacological treatment","volume":"23","author":"LeSage","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"10.1016\/j.phrs.2007.09.001_bib139","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neubiorev.2003.11.013","article-title":"The expanding effects of cocaine: studies in a nonhuman primate model of cocaine self-administration","volume":"27","author":"Porrino","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"issue":"1-2","key":"10.1016\/j.phrs.2007.09.001_bib140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(99)00059-5","article-title":"CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats","volume":"104","author":"Fattore","year":"1999","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib141","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00213-003-1484-0","article-title":"Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys","volume":"169","author":"Justinova","year":"2003","journal-title":"Psychopharmacology"},{"issue":"23","key":"10.1016\/j.phrs.2007.09.001_bib142","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1523\/JNEUROSCI.0951-05.2005","article-title":"The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys","volume":"25","author":"Justinova","year":"2005","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib143","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-4328(00)00311-9","article-title":"Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse","volume":"118","author":"Cossu","year":"2001","journal-title":"Behav Brain Res"},{"issue":"9","key":"10.1016\/j.phrs.2007.09.001_bib144","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.npp.1300707","article-title":"Lack of CB1 cannabinoid receptor impairs cocaine self-administration","volume":"30","author":"Soria","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib145","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.npp.1301109","article-title":"Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats","volume":"32","author":"Panlilio","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib146","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0091-3057(96)00445-5","article-title":"A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement","volume":"57","author":"Arnold","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2007.09.001_bib147","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2007.09.001_bib148","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-003-1441-y","article-title":"The validity of the reinstatement model of craving and relapse to drug use","volume":"168","author":"Katz","year":"2003","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2007.09.001_bib149","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00213-003-1470-6","article-title":"The reinstatement model and relapse prevention: a clinical perspective","volume":"168","author":"Epstein","year":"2003","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0529-6","article-title":"Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure","volume":"189","author":"Epstein","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2006.05.003","article-title":"An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives","volume":"53","author":"Fattore","year":"2007","journal-title":"Brain Res Rev"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib152","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002130051169","article-title":"Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats","volume":"147","author":"Schenk","year":"1999","journal-title":"Psychopharmacology"},{"issue":"6843","key":"10.1016\/j.phrs.2007.09.001_bib153","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/35084134","article-title":"Neuroadaptation. Incubation of cocaine craving after withdrawal","volume":"412","author":"Grimm","year":"2001","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.phrs.2007.09.001_bib154","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1523\/JNEUROSCI.0726-06.2006","article-title":"Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens","volume":"26","author":"Xi","year":"2006","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/10826087209026759","article-title":"Multiple drug use considered in the light of the stepping-stone hypothesis","volume":"7","author":"Cohen","year":"1972","journal-title":"Int J Addict"},{"issue":"7","key":"10.1016\/j.phrs.2007.09.001_bib156","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2105\/AJPH.74.7.668","article-title":"Patterns of drug use from adolescence to young adulthood. II. Sequences of progression","volume":"74","author":"Yamaguchi","year":"1984","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1016\/j.phrs.2007.09.001_bib157","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2105\/AJPH.74.7.673","article-title":"Patterns of drug use from adolescence to young adulthood. III. Predictors of progression","volume":"74","author":"Yamaguchi","year":"1984","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.phrs.2007.09.001_bib158","doi-asserted-by":"crossref","first-page":"447","DOI":"10.15288\/jsa.1992.53.447","article-title":"Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory","volume":"53","author":"Kandel","year":"1992","journal-title":"J Stud Alcohol"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib159","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1360-0443.2000.9545053.x","article-title":"Does cannabis use encourage other forms of illicit drug use?","volume":"95","author":"Fergusson","year":"2000","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib160","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0167-6296(03)00005-5","article-title":"Is cannabis a stepping-stone for cocaine?","volume":"22","author":"Van Ours","year":"2003","journal-title":"J Health Econ"},{"issue":"10","key":"10.1016\/j.phrs.2007.09.001_bib161","first-page":"491","article-title":"The prevalence of marijuana (cannabis) use and dependence in cocaine dependence","volume":"90","author":"Miller","year":"1990","journal-title":"NY State J Med"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib162","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0899-3289(05)80049-5","article-title":"Cannabis diagnosis of patients receiving treatment for cocaine dependence","volume":"2","author":"Miller","year":"1990","journal-title":"J Subst Abuse"},{"issue":"3","key":"10.1016\/j.phrs.2007.09.001_bib163","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:BEGE.0000017868.07829.45","article-title":"Cannabis and other illicit drugs: comorbid use and abuse\/dependence in males and females","volume":"34","author":"Agrawal","year":"2004","journal-title":"Behav Genet"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib164","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.mp.4000247","article-title":"Cannabinoid receptor gene (CNR1): association with i.v. drug use","volume":"2","author":"Comings","year":"1997","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2007.09.001_bib165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mp.4000925","article-title":"Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence","volume":"6","author":"Covault","year":"2001","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2007.09.001_bib166","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ajmg.b.30325","article-title":"Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence","volume":"141","author":"Herman","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatry Genet"},{"issue":"2","key":"10.1016\/j.phrs.2007.09.001_bib167","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.tpj.6500352","article-title":"(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population","volume":"6","author":"Ballon","year":"2006","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.phrs.2007.09.001_bib168","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02791072.1999.10471776","article-title":"Therapeutic use of cannabis by crack addicts in Brazil","volume":"31","author":"Labigalini","year":"1999","journal-title":"J Psychoactive Drugs"},{"issue":"8","key":"10.1016\/j.phrs.2007.09.001_bib169","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1176\/appi.ajp.162.8.1507","article-title":"Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study","volume":"162","author":"Aharonovich","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2007.09.001_bib170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.npp.1301034","article-title":"Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference","volume":"32","author":"Hansson","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661807001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661807001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:33:39Z","timestamp":1737398019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661807001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":170,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1043661807001600"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2007.09.001","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}